Dopharma and RIPAC-LABOR Celebrate Ground-Breaking Ceremony for New Production Facility for Existing Vaccines in the Potsdam Science Park
Raamsdonksveer, NL / Potsdam, 28.02.2025 | Dopharma Group and its subsidiary RIPAC-LABOR GmbH are pleased to announce the official groundbreaking ceremony for their new state-of-the-art autogenous vaccine production facility in the Technology Campus of the Potsdam Science Park. In the presence of Mike Schubert (Lord Mayor of the federal State Capital of Potsdam), Wijnand de Bruijn (Dopharma Group), Heiko Rüdiger (RIPAC-LABOR), Thilo Mehlhase (PBM architects) and Agnes von Matuschka (Site Management Golm – Standortmanagement Golm GmbH), the first milestone of this important project was set. This significant step underlines the company’s strategic expansion and commitment to meeting future regulatory standards. The new production facility is designed to comply with the upcoming Good Manufacturing Practice (GMP) guidelines expected in the European Union.
Ahead of European Legislation
Although the EU regulatory timeline has recently been delayed, Dopharma Group and RIPAC-LABOR remain committed to their responsibilities and are proactively investing in the future of existing vaccines by moving forward with the first phase of this ambitious project. “It is important to continue investing in the future, regardless of the EU timeline. The Dopharma Group firmly believes that herd vaccines will play an essential role in livestock production. They focus on prevention and expand the veterinarians’ toolbox to ensure animal health,” emphasizes Wijnand de Bruijn, CEO Business of the Dopharma Group. The new production facility will increase the capacity and efficiency of the production of stock vaccines. This will ensure a continuous supply of high-quality, customized solutions for veterinarians and farmers. This investment underlines the company’s commitment to innovation, animal health and sustainable agricultural production.
RIPAC-LABOR: The Perfect Partner for Herd Vaccines and Veterinary Diagnostics
Over the years, RIPAC-LABOR has established itself as a reliable partner for veterinary diagnostics and livestock vaccines in Europe. As part of the Dopharma Group, investments in knowledge and expertise are assured, and today’s ground-breaking ceremony is a clear sign of this. “We are very satisfied with the development of recent years. Thanks to the good cooperation with the city of Potsdam, our architectural firm PBM GR.UP Leipzig and the support of the Dopharma Group, we can celebrate this milestone today and reaffirm our confidence in Potsdam as a location for innovation,” summarizes Heiko Rüdiger, CEO RIPAC-LABOR.
About RIPAC-LABOR GmbH
RIPAC-LABOR GmbH, a wholly owned subsidiary of Dopharma International B.V., specializes in veterinary diagnostics and the production of stock vaccines for livestock. These customized vaccines offer targeted protection against herd-specific pathogens and are an essential tool in the prevention and control of infectious diseases. By expanding its production capacities, RIPAC-LABOR is strengthening the market position of the Dopharma Group in the European veterinary pharmaceutical market. The company currently employs 48 academic specialists, experienced laboratory technicians and other well-trained staff.
About the Dopharma Group
Dopharma is a family-run pharmaceutical company that has been developing and producing high-quality veterinary pharmaceuticals for farm animals since 1969. 95% of veterinary products are manufactured in the company’s GMP-certified production facilities, ensuring the highest quality standards and continuous innovation. Dopharma’s mission is to support the health and productivity of livestock worldwide through science-based solutions. www.dopharma.com
Press Contact
For media inquiries, please contact: communication (at) dopharma.com
In the picture: Ground-breaking ceremony at the Potsdam Science Park with (from left to right): Thilo Mehlhase (PBM architects), Wijnand de Brujin and Ruud de Rijke (both Dopharma), Mike Schubert (Lord Mayor of the state capital Potsdam), Heiko Rüdiger (RIPAC-LABOR GmbH) and Agnes von Matuschka (Standortmanagement Golm GmbH, Potsdam Science Park) on February 28, 2025.
Photo: Location Management Golm GmbH/Adam Sevens